YD Bio Limited Ordinary Shares
YDES · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$3 | $1 | $2 |
| Pre-Tax Income | -$2 | -$3 | $0 | $2 |
| Tax Expense | -$0 | $0 | $0 | -$0 |
| Net Income | -$2 | -$3 | $0 | $2 |
| % Margin | – | – | – | – |
| EPS | -0.65 | -0.98 | 0.1 | 0.54 |
| % Growth | 33.7% | -1,080% | -81.5% | – |
| EPS Diluted | -0.65 | -0.98 | 0.1 | 0.54 |
| Weighted Avg Shares Out | 3 | 3 | 4 | 4 |
| Weighted Avg Shares Out Dil | 3 | 3 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$3 | $0 | $2 |
| % Margin | – | – | – | – |